Global Cardiac Magnetic Resonance Imaging(MRI) Market Size By Type (Closed System, Opened System), By Application (Hospitals, Diagnostics Laboratories), By Region, And Segment Forecasts, 2023 to 2032

The Global Cardiac Magnetic Resonance Imaging (MRI) Market was valued at USD 2.4 billion in 2023 and is anticipated to reach USD 4.7 billion by 2031, expanding at a CAGR of 8.7% during the forecast period (2023–2031). Cardiac MRI plays a crucial role in non-invasive imaging of the heart, enabling precise evaluation of cardiac structure, function, and tissue characterization without ionizing radiation. The increasing prevalence of cardiovascular diseases (CVDs), growing demand for early diagnosis, and technological advancements in imaging systems are the primary drivers fueling the market's expansion.

Drivers:

1. Rising Incidence of Cardiovascular Diseases:

Heart disease remains the leading cause of death globally, prompting greater utilization of advanced imaging modalities like cardiac MRI to improve diagnosis and patient management.

2. Technological Innovations in MRI Systems:

Ongoing advancements such as 3T and 7T MRI systems, AI-enhanced imaging analysis, and faster scan protocols are improving the diagnostic capabilities of cardiac MRIs, thus encouraging wider adoption.

3. Growing Geriatric Population:

Aging populations are more susceptible to heart-related conditions. The need for accurate and detailed diagnostic tools, especially non-invasive ones like MRI, is increasing accordingly.

Restraints:

1. High Equipment and Operational Costs:

The initial investment for high-field MRI systems and the costs associated with trained personnel and facility requirements are significant barriers, especially for smaller healthcare facilities.

2. Limited Access in Emerging Markets:

Despite growing healthcare demand, several low- and middle-income countries still face infrastructural and economic barriers to implementing advanced imaging technologies.

Opportunity:

1. AI Integration for Enhanced Imaging:

Artificial intelligence (AI) integration in cardiac MRI platforms is improving imaging accuracy, reducing scan times, and facilitating quicker diagnosis. This presents lucrative growth potential, especially in AI-enabled diagnostic workflows.

2. Expanding Applications in Preventive Cardiology:

As preventive healthcare becomes a focus, cardiac MRI is increasingly used for risk stratification and early detection of asymptomatic heart diseases, offering untapped market potential.

Market by System Type Insights:

Open MRI Systems are emerging as a preferred option for patients with claustrophobia and those requiring comfort-focused scans, while Closed MRI Systems still dominate due to their superior image resolution. In 2023, Closed MRI Systems held the largest share, driven by their application in high-precision cardiovascular diagnostics. However, Open Systems are expected to witness faster growth, especially in outpatient and pediatric settings.

Market by End-use Insights:

Hospitals & Cardiology Clinics dominated the market in 2023, accounting for over 55% of global revenue. Their access to advanced MRI systems and availability of specialized cardiologists make them the primary setting for cardiac imaging. Meanwhile, Diagnostic Imaging Centers are experiencing accelerated growth due to their increasing use of specialized imaging services and cost-effective offerings for outpatients.

Market by Regional Insights:

North America led the global market in 2023, attributed to robust healthcare infrastructure, early adoption of advanced diagnostic technologies, and favorable reimbursement scenarios. Asia-Pacific is projected to witness the highest CAGR during the forecast period due to rising healthcare investments, increasing CVD burden, and growing awareness of early diagnosis across countries like China, India, and Japan.

Competitive Scenario:

Leading companies in the Global Cardiac MRI Market are focused on technological innovation, AI integration, strategic partnerships, and geographic expansion to strengthen their positions. Key players include:

Siemens Healthineers

GE HealthCare

Philips Healthcare

Canon Medical Systems Corporation

Hitachi Medical Systems

Esaote SpA

Key Developments:

In 2023, Siemens Healthineers launched a next-gen AI-powered cardiac MRI suite aimed at reducing scan times and improving image quality.

Philips Healthcare partnered with a U.S. research hospital in 2024 to pilot its latest MRI software for automated cardiac tissue mapping.

In 2025, GE HealthCare announced a global initiative to enhance access to cardiac MRI in rural and underserved regions via mobile imaging solutions.

Scope of Work – Global Cardiac Magnetic Resonance Imaging (MRI) Market

Report Metric Details

Market Size (2023) USD 2.4 billion

Projected Market Size (2031) USD 4.7 billion

CAGR (2023–2031) 8.7%

Market Segments System Type (Open, Closed), End-Use, Region

Growth Drivers Rise in CVDs, AI Integration, Aging Population

Opportunities AI-enhanced MRI, Preventive Cardiology Expansion

FAQs:

1. What is the current market size of the Global Cardiac Magnetic Resonance Imaging (MRI) Market?

The market was valued at USD 2.4 billion in 2023.

2. What is the major growth driver of the Global Cardiac Magnetic Resonance Imaging (MRI) Market?

The increasing incidence of cardiovascular diseases and demand for early, non-invasive diagnosis are major growth drivers.

3. Which is the largest region during the forecast period in the Global Cardiac Magnetic Resonance Imaging (MRI) Market?

North America is expected to remain the largest regional market throughout the forecast period.

4. Which segment accounted for the largest market share in the Global Cardiac Magnetic Resonance Imaging (MRI) Market?

Closed MRI Systems accounted for the largest market share by system type, and Hospitals & Cardiology Clinics led by end-use in 2023.

5. Who are the key market players in the Global Cardiac Magnetic Resonance Imaging (MRI) Market?

Key players include Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical, Hitachi, and Esaote.